NIH and Gates Foundation to invest $100 million each to develop gene therapies


NIH and the Bill & Melinda Gates Foundation invest in developing gene-based treatments.
Plan to develop gene based therapies for sickle cell disease and HIV.
Focus on making them available to those who need them the most.
Currently some of the most cutting-edge and effective treatments in medicine are unaffordable to the majority.
Because their price tags sometimes exceed $1 million.
Researchers have already recognized potential pathways for gene-based treatments.

New hope for the 37.9 million people worldwide living with HIV/AIDS
Read full article on Time Magazine website
More Gene Therapy information, news and resources
More Longevity Industry Investments information, news and resources